Literature DB >> 32934050

A case of dapsone-induced methaemoglobinaemia.

Yee Ann Tan1, Kai Choon Ng1, Seng Wee Cheo2, Tee Tat Khoo3, Qin Jian Low4.   

Abstract

Methaemoglobinaemia is an uncommon but potentially serious condition. It can be caused by congenital or acquired cause. Drug-induced methaemoglobinaemia is the commonest cause of acquired methaemoglobinaemia. The clinical signs and symptoms of methaemoglobinaemia include dyspnoea, desaturation, presence of saturation gap, headache, nausea and seizures depending on level of serum methaemoglobinaemia. We illustrate a case of dapsone-induced methaemoglobinaemia and its successful treatment by intravenous methylene blue. © Royal College of Physicians 2020. All rights reserved.

Entities:  

Keywords:  Dapsone; methaemoglobinaemia

Mesh:

Substances:

Year:  2020        PMID: 32934050      PMCID: PMC7539702          DOI: 10.7861/clinmed.2020-0364

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  3 in total

1.  Dapsone-induced methemoglobinemia: case of the blue lady.

Authors:  Paula Burke; Khurram Jahangir; Michael R Kolber
Journal:  Can Fam Physician       Date:  2013-09       Impact factor: 3.275

Review 2.  Dapsone-induced methemoglobinemia: a primer for clinicians.

Authors:  James A Barclay; Stamatina E Ziemba; Rami B Ibrahim
Journal:  Ann Pharmacother       Date:  2011-08-18       Impact factor: 3.154

3.  Dapsone-induced methemoglobinemia: "Saturation gap"-The key to diagnosis.

Authors:  Shivinder Singh; Navdeep Sethi; Sushmitha Pandith; Gouri Shankar Ramesh
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-01
  3 in total
  1 in total

1.  Transformation: fighting the past or building the new?

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.